Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl-Johan Malmberg

Showing results (71-80 of 127) with videos related to

Pageof 13
Sort By:
Cancer Immunology Research|June 23, 2017
<i>Ex Vivo</i> Expanded Adaptive NK Cells Effectively Kill Primary Acute Lymphoblastic Leukemia CellsLisa L Liu, Vivien Béziat, Vincent Y S Oei, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 6, 2011
Selenite induces posttranscriptional blockade of HLA-E expression and sensitizes tumor cells to CD94/NKG2A-positive NK cellsMonika Enqvist, Gustav Nilsonne, Oscar Hammarfjord, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 26, 2021
Anti-NKG2C/IL-15/anti-CD33 killer engager directs primary and iPSC-derived NKG2C<sup>+</sup> NK cells to target myeloid leukemiaEmily Chiu, Martin Felices, Frank Cichocki, et al.
The Journal of Clinical Investigation|August 30, 2016
Cognate HLA absence in trans diminishes human NK cell educationVanessa Landtwing, Ana Raykova, Gaetana Pezzino, et al.
Cancer Research|February 7, 2007
DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cellsMattias Carlsten, Niklas K Björkström, Håkan Norell, et al.
Nature Immunology|July 2, 2024
Pan-cancer profiling of tumor-infiltrating natural killer cells through transcriptional reference mappingHerman Netskar, Aline Pfefferle, Jodie P Goodridge, et al.
Cell Stem Cell|June 13, 2020
Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes In Vivo Persistence and Enhances Anti-tumor ActivityHuang Zhu, Robert H Blum, Davide Bernareggi, et al.
Oncoimmunology|July 29, 2016
Targeting B-cell neoplasia with T-cell receptors recognizing a CD20-derived peptide on patient-specific HLANadia Mensali, Fan Ying, Vincent Oei Yi Sheng, et al.
New Biotechnology|September 6, 2023
Affibody-based hBCMA x CD16 dual engagers for NK cell-mediated killing of multiple myeloma cellsKim Anh Giang, Thorstein Boxaspen, Yumei Diao, et al.
Cancer Immunology, Immunotherapy : CII|March 5, 2008
NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapyKarl-Johan Malmberg, Yenan T Bryceson, Mattias Carlsten, et al.
Pageof 13

Showing results (71-80 of 127) with videos related to

Sort By:
Pageof 13
Cancer Immunology Research|June 23, 2017
<i>Ex Vivo</i> Expanded Adaptive NK Cells Effectively Kill Primary Acute Lymphoblastic Leukemia CellsLisa L Liu, Vivien Béziat, Vincent Y S Oei, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 6, 2011
Selenite induces posttranscriptional blockade of HLA-E expression and sensitizes tumor cells to CD94/NKG2A-positive NK cellsMonika Enqvist, Gustav Nilsonne, Oscar Hammarfjord, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 26, 2021
Anti-NKG2C/IL-15/anti-CD33 killer engager directs primary and iPSC-derived NKG2C<sup>+</sup> NK cells to target myeloid leukemiaEmily Chiu, Martin Felices, Frank Cichocki, et al.
The Journal of Clinical Investigation|August 30, 2016
Cognate HLA absence in trans diminishes human NK cell educationVanessa Landtwing, Ana Raykova, Gaetana Pezzino, et al.
Cancer Research|February 7, 2007
DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cellsMattias Carlsten, Niklas K Björkström, Håkan Norell, et al.
Nature Immunology|July 2, 2024
Pan-cancer profiling of tumor-infiltrating natural killer cells through transcriptional reference mappingHerman Netskar, Aline Pfefferle, Jodie P Goodridge, et al.
Cell Stem Cell|June 13, 2020
Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes In Vivo Persistence and Enhances Anti-tumor ActivityHuang Zhu, Robert H Blum, Davide Bernareggi, et al.
Oncoimmunology|July 29, 2016
Targeting B-cell neoplasia with T-cell receptors recognizing a CD20-derived peptide on patient-specific HLANadia Mensali, Fan Ying, Vincent Oei Yi Sheng, et al.
New Biotechnology|September 6, 2023
Affibody-based hBCMA x CD16 dual engagers for NK cell-mediated killing of multiple myeloma cellsKim Anh Giang, Thorstein Boxaspen, Yumei Diao, et al.
Cancer Immunology, Immunotherapy : CII|March 5, 2008
NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapyKarl-Johan Malmberg, Yenan T Bryceson, Mattias Carlsten, et al.
Pageof 13